Task Forces

Task forces are projects that deal with specific topics that are relevant, controversial or new in the field. All EAACI members can apply for a specific task forces in alignment with the chair and secretary of a specific section or interest group. All task forces are supported by EAACI and have been approved by the Executive Committee.

All Task Forces

Filter

What are you looking for?

Category
- adolescent
- aerobiology and pollution
- allergen immunotherapy (AIT)
- AllergoOncology
- allergy asthma and a sport
- allergy diagnosis
- allied health and primary care
- anaphylaxis
- angioedema
- artificial intelligence (AI)
- asthma
- basic immunology
- biologicals
- comparative veterinary allergology
- consensus document
- COVID-19
- dermatology
- drug allergy
- EAACI position paper
- EAACI Task Force report
- ENT
- environmental allergy and climate change
- eosinophilic esophagitis (EoE)
- epidemiology
- epithelial cell biology
- exposome
- food allergy
- food allergy and anaphylaxis
- genomics and proteomics
- hypersensitivity
- immune deficiencies and autoimmunity
- immunomodulation and nutrition
- infections
- insect venom hypersensitivities
- mastocytosis and mast cells
- microbiome
- nasal polyposis
- occupational allergy
- ocular allergy
- OMIC technologies in allergy research
- One Health
- pediatrics
- prevention
- systems medicine
- T2 diseases
- transitional
Year
- 2013
- 2014
- 2015
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
Keywords
- nasal polyps…)
- sinusitis
- vaccines and mechanisms
- “omics” and systems biology
- “omics” and systems biology
- (reverse) zoonosis
- AAMP
- Abbott Laboratories
- Abdominal pain
- ABPA
- ACE2
- Acoustic rhinometry
- Adherence
- Adjuvant
- Adjuvants
- adolescent
- Adolescents
- adolesent and young adult (AYA)
- Adrenaline
- Adrenaline auto-injector
- adult
- adults
- adverse drug reaction
- advocacy
- aerd
- aerobiology
- aerosolization
- AGREE II
- Aimmune Therapeutics
- Air pollutant
- Air pollution
- Airborne enzyme
- airways
- AIT
- Algorithm
- ALK
- allegen immunotherapy (AIT)
- allergen
- allergen exposure challenge
- allergen exposure chamber
- allergen immunotherapy
- allergen immunotherapy (AIT)
- Allergen labelling
- Allergen sequence database
- allergen symphony
- Allergen-free foods
- Allergens and epitopes
- allergens and epitopes
- allergic asthma
- allergic bronchopulmonary aspergillosis
- allergic conjunctivitis
- Allergic conjunctivitis (AC)
- Allergic contact dermatitis
- allergic disease
- allergic diseases
- allergic rhinitis
- Allergic rhinitis (AR)
- allergicdiseases
- allergicrhinitis
- allergies to cats
- allergoid-mannan conjugates
- AllergoOncology WG
- Allergopharma
- allergy
- allergy diagnosis
- Allergy diagnosis
- allergy epidemiology
- allergy hypersensititvy
- allergy immunotherapy
- allergy management
- Allergy risk
- allergy test
- allergy therapeutics
- allergy treament
- allergy treatment
- Allergy treatment
- allergy/hypersensitivity
- alpha-gal allergy
- ALR
- Alternaria
- altitude
- Anaphylaxis
- Angioedema
- angiotensin-convertingenzyme2
- angiotensin-convertingenzymeII
- Animal models
- Anosmi
- anti-epileptic drugs
- antibiotics
- Antibodies
- antibody
- antibody-dependentenhancement
- antibodydynamics
- antigen presenting cells
- Antolimab
- Api m 10
- APOE
- ARPC1B
- Artificial intelligence
- Asthma
- asthma care
- asthma control
- asthma exacerbations
- asthma inflammatory
- asthma management
- asthma risk
- Asthma treatment
- Asthma treatment
- asthmatic patients
- Astrazeneca
- asymptomatic
- atopic dermatitis
- Atopic dermatitis
- Atopic dermatitis (AD)
- Atopic deseases
- Atopic eczema
- Atopic eosinophilic asthma
- atopy
- Autoallergen
- Autoimmunity
- Autoinflammation
- Avapritinib
- Azelastine fluticasone
- B cells
- B regulatory cells
- bacterial lysate
- bacterial lysates
- bacterial mucosal immunotherapy
- bacterial products
- Barrier
- Basic and Clinical Immunology Section
- Basic immunology
- basic mechanisms
- Basic mechanisms
- Basophil
- Basophil activation test
- basophil activation test (BAT)
- Bathing
- Bcells
- Beijing
- Benralizumab
- berotralstat
- Bet v 1
- beta-lactam
- beta-lactoglobulin
- Big data
- bigdata
- BioCryst
- Bioinformatics
- Biological detergents
- biologicals
- Biologics
- biomarker
- Biomarkers
- biosafety
- Biotin
- Birch
- Birch pollen
- blood
- blood eosinophil
- BluePrint Medicines
- BNT162b2
- Bovine milk
- Breast milk
- Breastfeeding
- Breg cells
- bronchial allergen challenge
- bronchial asthma
- bronchial thermoplasty
- bronchiectasis
- Bronchiolitis
- Bronchoconstriction
- BTK
- c-kit
- C1 inhibitor
- C1-INH
- cabbage
- cancer
- cannabis allergy
- case study
- cats
- causality
- Cellular test
- challenge tests
- Challenge tests
- chemotherapy
- Childhood allergies
- childhood asthma
- childhoodvaccination
- children
- china
- chlorhexidine
- chlorination by-products
- Chronic respiratory
- Chronic rhinosinusitis
- Chronic rhinosinusitis with nasal polyposis (CRSwNP)
- chronic rhinosinusitis with nasal polyps (CRSwNP)
- chronic spontaneous urticaria
- Chronic spontaneous urticaria (CSU)
- chronic urticaria
- chronicrhinosinusitis
- chronicrhinosinusitiswithnasalpolyps
- chronicurticaria
- chronis rhinosinusitis
- classification
- climate
- climate change
- Clinical aspects
- clinical cases
- clinical endotypes
- Clinical immunology
- Clinical immunology Food allergy
- Clinical practice
- clinical tolerance
- clinical trials
- clinicalimmunology
- Cluster analysis
- CMA
- Collegen-binding receptor
- common cold
- companion animals and pets
- Company Sponsored Symposia
- complex world of allergy
- compliance
- component resolved diagnosis
- Component resolved diagnosis (CRD)
- component-resolved diagnosis (CRD)
- Conjunctiva
- conjunctivitis
- Consensus
- consensus document
- contact allergen
- contact dermatitis
- Contact urticaria
- containment
- contraindications
- coronavirus
- coronavirusdisease2019
- Cost-effectiveness
- cough
- COVID
- COVID-19
- COVID-19 lockdown
- COVID-19 pandemic
- COVID-19 vaccine
- COVID-19 vaccines
- COVID-19[SupplementaryConcept]
- COVID-19diagnostictesting[SupplementaryConcept]
- COVID-19vaccines
- COVID‐19
- COVID19
- Cow's milk
- Cow's milk allergy
- CRISPR
- criticalillness
- Cross-reactivity
- CRSwNP
- CSL Behring
- Cutaneous manifestation
- cyclosporine
- cytokine
- DAMP
- danger signals
- Danger signs
- Danone/Nutricia
- dbv technologies
- dbv712
- Deep learning
- delabelling
- DELPHI
- Dendritic cells
- dermatologic diseases
- Dermatology
- desensitization
- dexamethasone
- DGAKI
- diagnosis
- diet
- dietary management
- Differential diagnosis
- digital anamorphosis
- disease (CRD)
- disease burden
- disease control
- disease model
- disease transmission
- disinfection by-products
- disruptive IgE antibody
- DNase
- Drug allergy
- drug allergy
- Drug desensitisation
- Drug hypersensitivity
- drug provocation test
- drug provocation test (dpt)
- Drug provocation tests
- dupilumab
- Dysbiosis
- E-cigarette
- eaaci hybrid congress 2021
- eaaci hybrid congress 2022
- eaaci2021
- early diet
- ECDA
- ecosystem
- eczema
- Education
- EETosis
- efficacy
- Egg allergy
- EGR-1
- eHealth
- Eldery
- Elimination diet
- Emollient
- Endotype
- Endotypes
- ENT
- ENT (rhinitis
- environment
- Environment and hygiene hypothesis
- Environment and Immunology StandUp Talks
- Environmental exposure chamber (EEC)
- environmentalhealth
- Enzyme-LinkedImmunosorbentAssay[Mesh]
- eosinophil
- eosinophilic diseases
- eosinophilic fasciitis
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Eosinophils
- Epicutaneous
- Epicutaneous immunotherapy
- Epidemiology
- epigenetic
- Epithelial barrier
- Epithelial barrier hypothesis
- epithelialcell
- Epithelium
- Epitome
- Epitope specific IgA
- Esophagitis
- EU
- European parliament
- evidence-based
- exacerbations
- exercise
- Exercise induced anaphylaxis (EIAn)
- Exercise induced asthma
- exposome
- faam-eurobat digital 2020
- Faes Farma
- fermentedvegetable
- fiber
- Flow cytometric
- Flow cytometry
- flow-diagram
- flowcytometry
- food additives
- food allergy
- Food allergy
- Food aversion
- food labelling
- Food processing
- food protein induced enterocolitis syndrome (FPIES)
- Food-dependent exercise-induced anaphilaxis (FDEIAn)
- Food-induced anaphylaxis (FIA)
- Fungi
- fungus
- Gene expression
- Genetics
- Genome-wide association study (GWAS)
- Global air quality
- global atlas
- glycans
- GRADE
- Grant application
- GSK
- guidelines
- gut microbiome
- Gut microbiota
- HAE
- HAL Allergy
- healthier environment
- Helicobacter pylori
- Helminth infection
- hereditary angioedema
- Hereditary angioedema (HAE)
- Histamine
- Histamine intolerance
- hives
- HMO
- Hologenome
- House dust mite
- House dust mite (HDM)
- house dust mites
- Human bronchial smooth muscle cells (BMSC)
- hygiene
- Hypereosinophilic syndrome (HES)
- hyperinflammation
- hypersensitivity
- hypersensitivity reactions
- ICD-11
- IgE
- IL-37b
- imaging
- Immune amnesia
- Immune deficiencies
- Immune health
- immune phenotype
- immune response
- immune system
- Immune tolerance
- immunecomplex
- immuneresponse
- Immunization
- immunodeficiencies
- immunoglobulinM
- immunoglobulins
- Immunologic tests
- Immunologic tests
- immunology
- Immunomodulators
- immunotherapy
- Immunotherapy and tolerance induction
- Immunotherapy clinical
- Immunotherapy vaccines and mechanisms
- Immunotherapy vaccines and mechanisms
- implementationscience
- In vitro assays
- Inborn errors of immunity (IEI)
- Infections
- inferiorturbinate
- Inflammasome
- Inflammation
- Inflammatory bowel disease (IBD)
- inflammatoryendotype
- innate immune training
- innate immunity
- Innate immunity
- Innate lymphoid cells and NK cells
- innateimmunity
- Innovation
- Insect Venom Allergy
- insects
- integrated care
- Integrines
- interferon
- Interferons
- Interleukins
- international classification of diseases (ICD)
- international consensus
- intradermal test
- Iodinated contrast media
- italy
- itch
- Kawasakisyndrome
- kimchi
- Lactobacillus
- lanadelumab
- learning methods
- LETI Pharma
- ligelizumab
- Lipid transfer protein (LTP)
- Local allergic rhinitis
- Lolium Perenne
- long-term immunity
- Long-term prophylaxis
- LTRA
- Lung diseases other than asthma and COPD
- lung function
- lung function test
- Lung function tests
- lymphocyte transformation test (LTT)
- Lymphocytes
- Machine learning
- Macrophages
- Malignant
- management
- marketing authorization
- Masitinib
- mast cell
- Mast cells
- Mast cells
- Mast cells Dermatology
- mastocytosis
- Mastocytosis scale (QLMS)
- mechanisms
- Medthority CME supported by Novartis
- memory B cells
- Menarini Group
- mental health
- Mepolizumab
- Metabolite
- metabolites
- Metabolomics
- Metalloproteinase 9
- methods
- mHealth
- Microbial Disease
- microbial products
- Microbiome
- microbiota
- MicroCrystalline
- micronutrient
- MicroRNA (miRNA)
- Mobile health (mHealth)
- Moisturisers
- Molecular phenotypes
- molecularinteractionassay
- Molecules
- monoclonal Abs
- monocytes
- MOOC
- MRGPRX2
- mRNA
- mRNA vaccines
- Multiple myeloma
- multisystem allergy
- multisysteminflammatorysyndrome
- mumps‐measles‐rubella
- myeloperoxidase
- nasal allergen challenge
- nasal endoscopy
- nasal polyposis
- nasal polyps…)
- neonates
- Nestlé Health Science
- Nestlé Nutrition Institute
- Neuroimmunology
- Neuronal control
- Neutralizing[Mesh]
- neutralizingantibody
- neutrophil extracellular traps (NETs)
- neutrophilextra-cellulartraps(NETs)
- neutrophils
- New challenges
- newborns
- Next generation
- NLR
- non-specialist care
- non-steroidal anti-inflammatory drugs (NSAID)
- non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
- noninvasive diagnosis
- Noucor
- Novartis
- Novel mechanisms
- NSAID
- nsaid-exacerbated respiratoy disease (NERD)
- Nutrition
- Obesity
- Occupational asthma
- occupational exposure
- Ocular allergy
- older (adults/people)
- older adults
- Olfactory disturbance
- Olink
- OM Pharma
- omalizumab
- omic
- One Health
- OneHealth
- Oral allergy syndrome (OAS)
- oral challenge
- oral food challenge
- Oral immunotherapy
- outbreak
- Outcome measures
- PAAAM 2021
- PAAM 2021
- PAAM Digital 2021
- paediatric awareness
- Paediatrics
- PAF
- PAMP
- Panallergen
- pandemic
- Particular matter (PM)
- Patch test
- Patch tests
- patient care
- patient reported outcome
- peak expiratory flow
- peak expiratory flow (PEF)
- Peanut
- Peanut allergy
- pediatric
- pediatric aspects
- pediatric asthma
- pediatric atopic dermatitis
- pediatrics
- Peptide immunotherapy
- perioperative allergy
- personalized medicine
- Personalized medicine
- pharmacoeconomics
- Pharmacology and pharmacogenomics
- Pharming
- Phase-3 study
- Phenotype
- phenotypes
- physiology
- Pine nut allergy
- PIPEline
- Placebo effect
- placebo effects
- Plane tree
- Platanus hybrida
- Pneumology
- pneumonia
- Polish Allergology Society
- Pollen
- Pollen food syndrome
- Pollen forecast
- Pollen monitoring
- pollutants
- pollution
- polyethilen glycol
- polyethylene glycol
- PRACTALL
- prebiotics
- Precision medicine
- precision medicine
- prediction
- Prediction model
- Pregnancy
- Prematurity
- Prevention
- primary care
- primary immunodeficiency
- Probiotic
- probiotics
- proctocolitis
- Prophylactic Treatment
- proresolvinglipids
- protection
- protectiveantibodies
- protein contact dermatitis
- proteomics
- Proteotomics
- Proton pump inhibitor
- pruritus
- Psoriasis
- psychological effects
- psychology
- pulmonary rehabilitation
- Purina Institute
- Quality-of-life
- qualitycriteria
- Questionnaire
- race
- Ragweed
- randomized controlled trial
- Rapid drug desensitization
- Real life
- real-life
- real-world evidence
- Recipe
- recreational exposure
- RED-ZONE
- Regulatory aspects
- regulatory authorities
- Relegating OCS to last resort: Creating a paradigm shift in asthma management
- Remodelling
- reslizumab
- respiratory allergies
- respiratory allergy
- Respiratory infections
- Revenio
- Rhinitis
- Rhinitis Monitoring
- Rhinoconjunctivitis
- Rhinosinusitis (RS)
- Rhinovirus
- risk assessment
- risk factors
- riskfactors
- RLR
- rupatadine
- safety
- SAM 2021
- SAM2021
- SANI
- Sanofi Regeneron
- SARC-CoV-2
- SARS-CoV
- SARS-CoV-2
- SARS-CoV-2 vaccine
- SARS‐CoV‐2
- Satellite Symposia
- SCARs (severe cutaneous adverse drug reactions)
- scientific career
- scoring system
- self‐management
- sensitization
- sensitization profile
- Sepsis
- sequencing (NGS)
- severe allergic reactions
- severe asthma
- Severe cutaneous adverse drug reactions (SCARs)
- severe cutaneous adverse drug reactons
- severe eisinophilic asthma
- severe type 2 asthma
- SevereAcuteRespiratorySyndromeCoronavirus2[SupplementaryConcept]
- severeallergicreactions
- severity
- sIgG
- Single nucleotide polymorphisms (SNPs)
- sinus
- sinusitis
- Skin
- skin allergy
- Skin barrier
- skin diseases
- skin test
- Skincare
- sleep pattern
- smell
- SoMe
- Spirometry
- sport
- Sports
- sputuminduction
- Stallergenes Greer
- standardization
- StandUp Talks
- Stevens-Johnson syndrome (SJS)
- Stratification
- subcutaneous immunotherapy
- Sublingual
- sublingual immunotherapy
- sulforaphane
- Sulfur mustard Stem cells
- survey
- Symptom scale
- Symptom score
- synbiotics
- system biology
- systematic mastocytosis
- Systemic mastocytosis (SM)
- T cells
- T cells
- t2 diseases
- Takeda
- TAKHZYRO
- Tcells
- technical standards
- teenager
- tele-health
- teleHealth
- telemedicine
- Terriers
- Tezepelumab
- Th2 cell
- Th2 sensitization
- therapies
- Thermo Fisher Scientific
- threshold dose
- Thunderstorm asthma
- TLR
- TMPRSS2
- tolerance
- Trained immunity
- trainedimmunity
- Transcriptome
- Transcriptomics
- transition
- Transition process
- translationalresearch
- transmissionofdisease
- treatment
- tree nut allergy
- Tree-nut allergy
- Trichinella spiralis
- Tryptase
- TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascade
- type 2 inflammation
- UCARE
- unmet needs
- Urban green spaces
- Urban particulate matter
- Urticaria
- urticaria in children
- urticarial vasculitis
- Vaccination
- vaccine
- Vaccines
- Vaping
- Venom and insect allergy
- venom immunotherapy
- Viral reactivation
- Virtual care
- Virus
- WAO
- wheal
- wheezing child
- white paper
- World Health Organization (WHO)
- WS 2023 Davos
- Xlinkedagammaglobulinemia
- yellow fever
- young adult
- young adults
- young children
Author
- Aberer, W.
- Achten, R.
- Adamiec, A.
- Adcock, I.
- Agache, I.
- Aggelides, X.
- Akdis, C.A.
- Akdis, M.
- Akin, C.
- Allegri, P.
- Altrichter, S.
- Alvarez-Cuesta, E.
- Alvarez-Perea, A.
- Alvaro-Lozano, M.
- Alviani, C.
- Ambrożej, D.
- Angier, E.
- Annesi-Maesano, I.
- Antolin-Amerigo, D.
- Antunes, C.
- Apoil, P.
- Arasi, S.
- Arcolaci, A.
- Ardern-Jones, M.R.
- Arkhipova, S.
- Arnold, A.
- Arrais, M.
- Asero, R.
- Atanaskovic-Markovic, M.
- Ayane, A.
- Aygören-Pürsün, E.
- Bacharier, L.
- Bachert, C.
- Baerenfaller, K.
- Bansal, P.
- Barbaud, A.
- Barber, D.
- Bartel, S.
- Bartra, J.
- Baumann, R.
- Bavbek, S.
- Bazan-Socha, S.
- Beausoleil, J.
- Beck, E.
- Beck, L.
- Bégin, P.
- Beken, B.
- Benito Villalvilla, C.
- Bergmann, C.
- Bernard, A.
- Bernstein, D.
- Bernstein, J.
- Besednjak-Kocijancic, L.
- Betschel, S.
- Beyer, K.
- Bianchini, R.
- Biedermann, T.
- Birrell, F.
- Bisyuk, Y.
- Blain, H.
- Blanca-Lopez, N.
- Blasi, F.
- Blümchen, K.
- Boccabella, C.
- Boguniewciz, M.
- Bohle, B.
- Böhm, I.
- Bonini, M.
- Borres, M.
- Bosco, A.
- Bosnic-Anticevich, S.
- Bossios, A.
- Bousquet, J.
- Boyce, J.
- Boyle, R.
- Bozek, A.
- Bozkurt, B.
- Braido, F.
- Branicka, O.
- Braun, A.
- Braunstahl, G.
- Bredenoord, A.
- Brignole-Baudouin, F.
- Brockow, K.
- Brough, H.A.
- Brucker, H.
- Brusselle, G.
- Burks, W.
- Busse, W.
- Caballero, M.
- Cabanillas, B.
- Cabrera, M.
- Calado, R.
- Calder, V.
- Calderon, M.
- Calvão, J.
- Camargo Lopes de Oliveira, L.
- Campbell, D.
- Canonica, G.W.
- Cardona, V.
- Carnés, J.
- Carter, M.
- Casale, T.
- Castells, M.
- Castillejo, G.
- Caubet, J.-C.
- Cavaleiro Rufo, J.
- Chaker, A.
- Chan, E.
- Chandra, A.
- Chawes, B.
- Chehade, M.
- Chivato, T.
- Cho, Y.
- Chung, K.
- Cianferoni, A.
- Cimbollek, S.
- Clark, A.
- Clark, E.
- Cogo, A.
- Cojanu, C.
- Comberiati, P.
- Constantinides, M.
- Corbett, M.
- Cornejo-Garcia, J.A.
- Corren, J.
- Corrigan, C.
- Coutinho, C.
- Couto, M.
- Craig, T.
- Cullinan, P.
- Cunha, I.
- Custovic, A.
- D'Amato, G.
- Davidescu, L.
- Dávila, I.
- de Blay, F.
- De Craemer, J.
- de Jong, N.
- de las Vecillas, L.
- de Silva, D.
- de Swart, R.
- de Waard-van der Spek, F.
- del Giacco, S.
- Delgado, L.
- Demoly, P.
- Descamps, V.
- Deschildre, A.
- Deshpande, D.
- di Bona, D.
- Diamant, Z.
- Diwakar, L.
- Doğru, M.
- Domínguez Andrés, J.
- Doña, I.
- Dörr, T.
- Dramburg, S.
- Drijver-Messelink, M.T.
- du Toit, G.
- Dunn Galvin, A.
- DunnGalvin, A.
- Durham, S.
- Eberlein, B.
- Ebisawa, M.
- Ebo, D.G.
- Eggel, A.
- Eguiluz-Gracia, I.
- Eguiluz, I.
- Eigenmann, P.
- Eiwegger, T.
- Elenius, V.
- Eljaszewicz, A.
- Emeryk, A.
- Emson, C.
- Eyerich, K.
- Fakhimahmadi, A.
- Farkas, H.
- Fauquert, J.
- Favaro, A.
- Feketea, G.
- Feleszko, W.
- Fernández Santamaría, R.
- Fernández-Rivas, M.
- Ferrando anaut, P.
- Fieten, K.B.
- Figueras Alsius, M.
- Fiocchi, A.
- Flokstra – de Blok, B.M.J.
- Florsheim, E.
- Fokkens, W.
- Fonseca, J.
- Forastiere, F.
- Freemantle, N.
- Fritzsching, B.
- Fu, W.
- Gainsborough, F.
- Galvan Blasco, P.
- Gamez, C.
- Gappa, M.
- Garvey, L.H.
- Gaudenzio, N.
- Gelincik, A.
- Geng, B.
- Gennery, A.
- Genuneit, J.
- Gern, J.
- Gerth van Wijk, R.
- Gervasoni, M.E.
- Gevaert, P.
- Gherasim, A.
- Giménez-Arnau, A.
- Giovannini, M.
- Gobert, D.
- Golding, M.
- Gomes, E.R.
- Gomes, J.
- Goncalo, M.
- Gonçalo, M.
- González Díaz, S.
- González germán, M.
- Goodman, R.
- Goossens, A.
- Gore, C.
- Grattan, C.
- Greenhawt, M.
- Grigg, J.
- Grimshaw, K.
- Gunawardana, N.
- Gupta, R.
- Gutermuth, J.
- Guttman-Yassky, E.
- Guttman, E.
- Hagemann, J.
- Halken, S.
- Hamilton, J.
- Hartmann, K.
- Heffler, E.
- Heine, R.
- Heldner, A.
- Hellings P.
- Hermuth-Kleinschmidt, K.
- Hilger, C.
- Hirahara, K.
- Hoffmann-Sommergruber, K.
- Holgate, S.
- Holmdahl, I.
- Holmes, S.
- Howarth, P.
- Huang, Y.
- Humbert, M.
- In't Veen, H.
- Izquierdo, E.
- Izuhara, K.
- Jackson, D.
- Jacobsen, L.
- Jakob, T.
- Janda, J.
- Jeebhay, M.
- Jeimy, S.
- Jensen-Jarolim, E.
- Jesenak, M.
- Jiménez-Saiz, R.
- Johnston, S.
- Jones, A.
- Juskiene, I.
- Jutel, M.
- K Chu, D.
- Kang, M.
- Kappen, J.
- Kase Tanno, L.
- Kelleher, M.
- Kessel, A.
- Khaitov, M.
- Khaleva, E.
- Kheradmand, F.
- Kiani-alikhan, S.
- Kılıç, A.
- Kleine-Tebbe, J.
- Kleuskens, M.
- Klimek, L.
- Knibb, R.
- Knol, E.
- Kocatürk, E.
- Köhler, V.
- Korath, A.D.J.
- Korn, S.
- Kortekaas Krohn, I.
- Kosowska, A.
- Kothalawala, D.
- Kozlik, P.
- Kucharczyk, A.
- Kuna, P.
- Kündig, T.
- Kupczyk, M.
- Kuziemski, K.
- Lack, G.
- Lang, D.
- Larché, M.
- Larenas-linnemann, D.
- Lau, S.
- Lauerma, A.
- Lee, Y.
- Leonardi, A.
- Levy, D.
- Liu, A.
- Lopata, A.
- Mack, D.
- Madrigal-Burgaleta, R.
- Magerl, M.
- Mahler, V.
- Mäkelä, M.
- Maleki, S.
- Malinovschi, A.
- Malmberg, P.L.
- Mantovani, A.
- Marcoux, D.
- Marrs, T.
- Marsella, R.
- Martins, C.
- Maspero, J.
- Mastalerz, L.
- Mathioudakis, A.
- Matricardi, P.
- Matucci, A.
- Maurer, M.
- Mayerhofer, H.
- Mayorga, C.
- McSorley, H.
- Melén, E.
- Menzies-Gow, A.
- Meyer, R.
- Michel, M.
- Mikkelsen, A.
- Mockenhaupt, M.
- Moloudizargari, M.
- Montimer, K.
- Mori, F.
- Mortz, C.G.
- Mösges, R.
- Moya, B.
- Mueller, R.S.
- Mukherjee, M.
- Mullol, J.
- Muraro, A.
- Myszkowska, D.
- Nadeau, K.C.
- Nasser, S.
- Novak, N.
- Nutten, S.
- Nwaru, B.
- O'B Hourihane, J.
- O’Mahony, L.
- Ogese, M.
- Ogg, G.
- Ogneva, D.
- Ollert, M.
- Ong, P.Y.
- Onorato, G.L.
- Pagani, M.
- Pali-Schöll, I.
- Paller, A.
- Palomares, O.
- Paoletti, G.
- Papadopoulos, N.
- Paplinska-Goryca, M.
- Park, H.
- Pascal, M.
- Pasmans, S.
- Pavlova, K.
- Pavord, I.
- Peden, D.
- Pérez de Llano, L.
- Perkin, M.
- Permaul, P.
- Peters, A.
- Pfaar, O.
- Pfaller, B.
- Pietikäinen, S.
- Pite, H.
- Pitsios, C.
- Poli, A.
- Popescu, F.
- Porsbjerg, C.
- Portelli, M.
- Price, O.J.
- Prunicki, M.
- Qazi, K.
- Quirce, S.
- Rabe, K.F.
- Radzikowska, U.
- Recke, A.
- Reese, I.
- Reginald, K.
- Renz, H.
- Reynolds, N.
- Ricci, C.
- Roberts, G.
- Roberts, G.
- Rodrigo-Muñoz, J.
- Rodrigues-Cernadas, J.
- Rodríguez Del Río, P.
- Rondon, C.
- Rossi, A.
- Rostaher, A.
- Roth-Walter, F.
- Rothenberg, M.
- Rouger, M.
- Rovati, G.E.
- Rubin, E.
- Rudenko, M.
- Rustemeyer, T.
- Ryan, D.
- Sabato, V.
- Sabouraud, D.
- Sadeghi, S.
- Sala Cunill, A.
- Salapatek, A.
- Sampson, H.
- Sandoval-Ruballos, M.
- Santos, A.
- Sastre, J.
- Satyaraj, E.
- Savic, S.
- Scadding, G.
- Scheib, N.
- Scherrer, K.
- Schmid, B.
- Schuijs, M.
- Schwarze, J.
- Sediva, A.
- Sekerel, B.
- Semernik, O.
- Serrano, C.
- Sevciovic Grumach, A.
- Shamji, M.H.
- Siebenhaar, F.
- Siegfried, E.
- Skypala, I.J.
- Smolinska, S.
- Sokolowska, M.
- Solinski, M.
- Song, K.
- Sorensen, K.
- Spanevello, A.
- Spergel, J.
- Spolak-Bobryk, N.
- Spriggs, K.
- Stevens, W.
- Stobiecki, M.
- Stratton. R.
- Straumann, A.
- Sturm, G.
- Sublett, J.
- Suojalehto, H.
- Suprun, M.
- Swanson, W.S.
- Szajewska, H.
- Szefler, S.
- Szymanski, L.
- Tan, B.
- Tanno, L.
- Tham, E.
- Thibaudon, M.
- Thien, F.
- Thirumala Krishna, M.
- Togias, A.
- Tomazic, P.
- Torrado español, I.
- Torres, M.J.
- Torun, E.
- Traidl-Hoffmann, C.
- Tramper-Stranders, G.
- Trautmann, A.
- Troy, N.
- Tsabouri, S.
- Tsilochristou, O.
- Ueki, S.
- Untersmayr, E.
- Vaia, E.
- Van Bilsen, J.
- Van Cuilenborg, V.
- van den Berge, M.
- Van Dijk, Y.
- van Neerven, R.
- van Ree, R.
- Van Schijndel, H.
- Van Weissenbruch, R.
- Vandenplas, Y.
- Vassilopoulou, E.
- Vazquez-Ortiz, M.
- Vega Castro, A.
- Venter, C.
- Verhasselt, V.
- Villaseñor solis, A.
- Vitte, J.
- Vlieg- Boerstra, B.
- Vogelberg, C.
- von Mutius, E.
- Vultaggio, A.
- Walsted, E.S.
- Walter, J.
- Wang, J.
- Wardzynska, A.
- Warner, A.
- Wechsler, M.
- Weidner, J.
- Weinberger, B.
- Werfel, T.
- Wiehn, E.
- Williams, S.
- Wong, C.
- Worm, M.
- Xepapadaki, V.
- Yepes-Nuñez, J.J.
- Yuste-Montalvo, A.
- Zednik, K.
- Zhang, L.
- Zieglmayer, P.
- Zissler, U.M.
- Zuberbier, T.

Task Force 09/06/2022

Allergic diseases in adolescents and young people, towards better patient centred care

Read about this Task Force
Task Force 09/06/2022

EAACI Food Allergy Guidelines

Read about this Task Force
Task Force 09/06/2022

One Health in Allergology

Read about this Task Force
Task Force 09/06/2022

ENIGMA (Exploring Non-IgE mediated Allergy)

Read about this Task Force
Task Force 09/06/2022

Work-related asthma questionnaires and algorithms for screening and surveillance (WAQASS)

Read about this Task Force
Task Force 09/06/2022

Validation of Clinical endpoints in AIT (with MASK technology)

Read about this Task Force
Task Force 09/06/2022

Interdisciplinary TF group “Allergen Challenge Chambers (AEC): state of the arts and needs for the future”_ Phase III

Read about this Task Force
Task Force 09/06/2022

Interdisciplinary TF group “Definition of clinical-relevant thresholds of allergen-exposure for analysis of outcomes in AIT”_ Phase III

Read about this Task Force
Task Force 09/06/2022

Food Allergen Thresholds

Read about this Task Force
Task Force 09/06/2022

Understanding hypersensitivity reactions to COVID 19 vaccines

Read about this Task Force
Task Force 09/06/2022

Basophil activation test in the evaluation of Drug Hypersensitivity Reactions

Read about this Task Force
Task Force 09/06/2022

Drug provocation tests: updated recommendations of the drug allergy group of EAACI

Read about this Task Force
Task Force 09/06/2022

Joint-TF of CVA and One Health “Intersection of Comparative Allergology and One Health”

Read about this Task Force
Task Force 09/06/2022

Omic technologies in allergy research

Read about this Task Force
Task Force 09/06/2022

EAACI JM Collaboration with European Respiratory Society (ERS) Early Career Members (ECM)

Read about this Task Force
Task Force 09/06/2022

EAACI JM Collaboration with European Rhinologic Society (ERhS) Junior Member (JM) Committee

Read about this Task Force
Task Force 09/06/2022

Improving Chronic Urticaria Management in Pediatrics – (ICUMP)

Read about this Task Force
Task Force 09/06/2022

Feeding difficulties in children with food allergies

Read about this Task Force
Task Force 09/06/2022

Harmonization of clinical outcomes of efficacy in Food-AIT trials

Read about this Task Force
Task Force 09/06/2022

Micronutrients

Read about this Task Force
Task Force 09/06/2022

Systematic review on the dietary interventions in children after acute respiratory or skin infections

Read about this Task Force
Task Force 09/06/2022

Ultraprocessed foods and allergy outcomes: Stopping a global epidemic

Read about this Task Force
Task Force 09/06/2022

E-learning material about AllergoOncology

Read about this Task Force
Task Force 09/06/2022

Granulocytes (mast cells, basophils, neutrophils eosinophils): understanding their roles in allergy and tumour immunity

Read about this Task Force
Task Force 09/06/2022

AllergoOncology in the Era of Personalized, Stratified and Precision medicine (STRATALLON)

Read about this Task Force
Task Force 09/06/2022

Macrophage role in Allergy and Cancer: Novel therapeutic opportunities

Read about this Task Force
Task Force 09/06/2022

Severe atopic dermatitis associated with hypogammaglobulinemia

Read about this Task Force
Task Force 09/06/2022

Human Skin Microbiota

Read about this Task Force
Task Force 09/06/2022

Systematic biobanking for precision medicine in asthma and allergic diseases

Read about this Task Force
Task Force 09/06/2022

Conscious and rational use of antibiotics in allergic diseases

Read about this Task Force
Task Force 09/06/2022

EAACI Recommendations: Management and Treatment Algorithm in Preschool Wheezing

Read about this Task Force
Task Force 09/06/2022

EAACI position paper on the diagnosis and therapeutic management of allergic bronchopulmonary aspergillosis (ABPA)

Read about this Task Force
Task Force 09/06/2022

Immunopharmacology: non-biological therapeutic approaches in allergy and clinical immunology

Read about this Task Force
Task Force 09/06/2022

Health care provider and patient perceptions regarding Covid-19 vaccines

Read about this Task Force
Task Force 09/06/2022

Immunometabolism in allergy and asthma – AllerIMMET

Read about this Task Force
Task Force 09/06/2022

Public outreach for immunological mechanisms in allergies and asthma

Read about this Task Force
Task Force 09/06/2022

Principles for targeting eicosanoids in the treatment of asthma and allergic diseases

Read about this Task Force
Task Force 09/06/2022

Drug-Induced Periocular and Ocular Surface Disorders

Read about this Task Force
Task Force 09/06/2022

Development of mHealth biomarkers for allergic diseases based on CSMS and machine learning

Read about this Task Force
Task Force 09/06/2022

CRS Endotypes

Read about this Task Force
Task Force 09/06/2022

Cannabis Allergy Working Group

Read about this Task Force
Task Force 09/06/2022

Blister fluid analysis in allergic diseases

Read about this Task Force
Task Force 09/06/2022

Food allergy in children with atopic dermatitis: an algorithm for diagnosis and risk evaluation

Read about this Task Force
Task Force 09/06/2022

Urticaria and anaphylaxis in endurance and ultra-endurance athletes: a proposal for pre-race risk assessment

Read about this Task Force
Task Force 09/06/2022

Diagnosis and management of allergic and respiratory disease in sports

Read about this Task Force
Task Force 09/06/2022

Asthma prevalence management in pregnancy

Read about this Task Force
Task Force 09/06/2022

Anti-inflammatory effect of anti-muscarinic antagonists

Read about this Task Force
Task Force 09/06/2022

High altitude climate treatment

Read about this Task Force

Show more Task Forces (36)

Task Forces

All Task Forces

What are you looking for?

Allergic diseases in adolescents and young people, towards better patient centred care

EAACI Food Allergy Guidelines

One Health in Allergology

ENIGMA (Exploring Non-IgE mediated Allergy)

Work-related asthma questionnaires and algorithms for screening and surveillance (WAQASS)

Validation of Clinical endpoints in AIT (with MASK technology)

Interdisciplinary TF group “Allergen Challenge Chambers (AEC): state of the arts and needs for the future”_ Phase III

Interdisciplinary TF group “Definition of clinical-relevant thresholds of allergen-exposure for analysis of outcomes in AIT”_ Phase III

Food Allergen Thresholds

Understanding hypersensitivity reactions to COVID 19 vaccines

Basophil activation test in the evaluation of Drug Hypersensitivity Reactions

Drug provocation tests: updated recommendations of the drug allergy group of EAACI

Joint-TF of CVA and One Health “Intersection of Comparative Allergology and One Health”

Omic technologies in allergy research

EAACI JM Collaboration with European Respiratory Society (ERS) Early Career Members (ECM)

EAACI JM Collaboration with European Rhinologic Society (ERhS) Junior Member (JM) Committee

Improving Chronic Urticaria Management in Pediatrics – (ICUMP)

Feeding difficulties in children with food allergies

Harmonization of clinical outcomes of efficacy in Food-AIT trials

Micronutrients

Systematic review on the dietary interventions in children after acute respiratory or skin infections

Ultraprocessed foods and allergy outcomes: Stopping a global epidemic

E-learning material about AllergoOncology

Granulocytes (mast cells, basophils, neutrophils eosinophils): understanding their roles in allergy and tumour immunity

AllergoOncology in the Era of Personalized, Stratified and Precision medicine (STRATALLON)

Macrophage role in Allergy and Cancer: Novel therapeutic opportunities

Severe atopic dermatitis associated with hypogammaglobulinemia

Human Skin Microbiota

Systematic biobanking for precision medicine in asthma and allergic diseases

Conscious and rational use of antibiotics in allergic diseases

EAACI Recommendations: Management and Treatment Algorithm in Preschool Wheezing

EAACI position paper on the diagnosis and therapeutic management of allergic bronchopulmonary aspergillosis (ABPA)

Immunopharmacology: non-biological therapeutic approaches in allergy and clinical immunology

Health care provider and patient perceptions regarding Covid-19 vaccines

Immunometabolism in allergy and asthma – AllerIMMET

Public outreach for immunological mechanisms in allergies and asthma

Principles for targeting eicosanoids in the treatment of asthma and allergic diseases

Drug-Induced Periocular and Ocular Surface Disorders

Development of mHealth biomarkers for allergic diseases based on CSMS and machine learning

CRS Endotypes

Cannabis Allergy Working Group

Blister fluid analysis in allergic diseases

Food allergy in children with atopic dermatitis: an algorithm for diagnosis and risk evaluation

Urticaria and anaphylaxis in endurance and ultra-endurance athletes: a proposal for pre-race risk assessment

Diagnosis and management of allergic and respiratory disease in sports

Asthma prevalence management in pregnancy

Anti-inflammatory effect of anti-muscarinic antagonists

High altitude climate treatment